ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,296.81
-0.01%
Dow Jones
39,933.10
0.16%
US Dollar vs MXN
16.6134
-0.40%
Brent Oil
83.515
0.37%
Bitcoin
66,994.85
2.69%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ARYA Sciences Acquisition Corporation IV (ARYD)

  7. ARYA Sciences Acquisition Corporation IV (ARYD) Noticias

ARYD

ARYA Sciences Acquisitio... (ARYD)

ARYA Sciences Acquisition Corporation IV
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARYD
FechaHoraFuenteTítuloSímboloCompañía
16/05/202415:41Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
16/05/202415:15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
06/05/202405:25GlobeNewswire Inc.Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd WiderNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
28/02/202416:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
26/02/202415:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
14/02/202415:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
14/02/202405:29PR Newswire (US)Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation TechnologiesNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
01/02/202416:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
22/01/202416:20Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
09/11/202315:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/06/202315:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
12/05/202315:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
31/03/202315:33Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
27/02/202305:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
14/02/202309:22Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
10/02/202315:46Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
31/01/202316:28Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
31/03/202208:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
24/02/202206:18Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
24/02/202206:00GlobeNewswire Inc.ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market ConditionsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
14/02/202209:30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
29/09/202116:13Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
29/09/202105:30GlobeNewswire Inc.Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
25/02/202119:04GlobeNewswire Inc.ARYA Sciences Acquisition Corp IV Announces Pricing of $130 Million Initial Public OfferingNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
 Showing the most relevant articles for your search:NASDAQ:ARYD

Su Consulta Reciente

NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
EURUSD
Euro vs US Dollar
NASDAQ
MSFT
Microsoft
COIN
BTCUSD
Bitcoin
AMEX
SPY
SPDR S&P 500
NYSE
XOM
Exxon Mobil
NYSE
DIS
Walt Disney
NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
COIN
SOLUSD
Solana
CCOM
US30
US 30
NYSE
AXP
American Express
NYSE
MCD
McDonalds
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados